Skip to main content
. 2025 Jun 2;14(4):1475–1493. doi: 10.1007/s40120-025-00765-3

Table 3.

Regression analyses on the impact of incremental ‘good ON-time’ on clinical, humanistic, and economic burden in the G7 population

Outcome Change in burden with every 1-h increase in ‘good ON-time,’ adjusted ratio/coefficient (95% CI) p value
Clinical burden
 Uncontrolled motor symptoms, OR 0.79 (0.62, 1.01) 0.060
 Uncontrolled non-motor symptoms, OR 0.88 (0.84, 0.96) 0.004*
 Number of falls in last 12 months relating to PD, IRR 0.91 (0.87, 0.95) < 0.001*
 Number of PD treatment classes (1 vs 2 +), IRR 0.91 (0.86, 0.97) 0.006*
 MDS-UPDRS total score (all parts), coefficient − 2.68 (− 6.18, 0.82) 0.129
Humanistic burden
 ADL independence, OR 1.19 (1.03, 1.37) 0.013*
 UPDRS total score, coefficient − 3.70 (− 6.03, − 1.36) 0.002*
 EQ-5D, coefficient 0.03 (0.01, 0.05) 0.001*
 EQ-5D VAS, coefficient 1.89 (0.95, 2.82) < 0.001*
 PDQ-39, coefficient − 1.49 (− 2.46, − 0.52) 0.003*
 ZBI, coefficient − 0.74 (− 2.08, 0.60) 0.276
Economic burden (healthcare resource utilization and costs)
 Hospitalizations (including surgery) in the last 12 months, OR 0.89 (0.83, 0.95) 0.001*
    Hospitalization costs ($), coefficient − 2496.98 (− 5708.52, 714.55) 0.128
 ICU admission in last 12 months, OR 0.73 (0.60, 0.89) 0.002*
 Number of ER visits in last 12 months, IRR 0.92 (0.86, 0.98) 0.013*
    ER visit costs ($), coefficient − 2176. 10 (− 4389.16, 36.95) 0.054
 Number of PD consultations in last 12 months, IRR 0.99 (0.94, 1.05) 0.851
    Consultation costs ($), coefficient − 11.96 (− 108.19, 84.26) 0.807
 Number of scans for PD in last 12 months, IRR 1.00 (0.95, 1.05) 0.994
    Scan costs ($), coefficient 15.67 (− 36.12, 67.46) 0.553
 Respite care, OR 0.93 (0.87, 1.00) 0.051
    Respite care costs ($), coefficient − 12,344.30 (− 24,598.03, − 90.57) 0.048*
 Professional care partner status, OR 0.89 (0.83, 0.95) < 0.001*
    Professional care costs ($), coefficient − 51.88 (− 1588.65, 1484.89) 0.947
 Non-professional care partner status, OR 1.00 (0.94, 1.06) 0.968
 Mean total costs ($), coefficient − 8602.24 (− 12,192.70, − 5011.77) < 0.001*

ADL, activity of daily living; CI, confidence interval; EQ-5D, EuroQol 5-Dimension; EQ-5D VAS, EuroQol 5-Dimension visual analog scale; ER, emergency room; ICU, intensive care unit; IRR, incidence rate ratio; MDS, Movement Disorder Society; OR, odds ratio; PD, Parkinson’s disease; PDQ-39, Parkinson’s Disease Questionnaire-39; UPDRS, Unified Parkinson's Disease Rating Scale; ZBI, Zarit Burden Interview

*Values are statistically significant